NCT03696069View on ClinicalTrials.gov

A Study is to Understand the Treatment Patterns for Immunotherapy Agents and BRAF/MEK Inhibitors Used in the Treatment of Advanced Melanoma

CompletedOBSERVATIONAL
Enrollment

501

Participants

Timeline

Start Date

January 9, 2019

Primary Completion Date

December 27, 2019

Study Completion Date

February 14, 2020

Conditions
Melanoma
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

02199

Local Institution, Boston

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY